...
...
Next Story

Double trouble

Updated on: Feb 12, 2008, 12:43:39 IST
Reuters | By , New York
Prefer HTon Google
HT Image
HT Image
Advertisement

People who use two or more anti-inflammatory drugs to help control pain could put their quality of life at risk, says study.

People who use two or more non-steroidal anti-inflammatory drugs (NSAIDs) to help control pain have a worse health-related quality of life than their peers who use only one, results of a study suggest."Patients may self-manage their pain to improve their daily activities by taking more than one NSAID. However, by attempting to obtain symptom relief, patients may be putting themselves at risk for complications," Dr Stacey H. Kovac, from the Durham VA Medical Centre in North Carolina, and colleagues note in the medical journal Arthritis Care and Research.

Prior research has established a strong link between multiple NSAID use and gastrointestinal problems, but it was unclear if this practice affected health-related quality-of-life.

To investigate, Kovac's team interviewed 138 patients from a large regional managed care organization who had filled one or more NSAID prescription between February and August 2002.

Whether multiple NSAID use impairs health-related quality of life itself or whether it simply reflects a more severe underlying disease that is responsible will require further study, the investigators note.

 
Catch every big hit, every wicket with Crick-it, a one stop destination for Live Scores, Match Stats, Quizzes, Polls & much more. Explore now!.

Catch your daily dose of Fashion, Taylor Swift, Health, Festivals, Travel, Relationship, Recipe and all the other Latest Lifestyle News on Hindustan Times Website and APPs.
Catch every big hit, every wicket with Crick-it, a one stop destination for Live Scores, Match Stats, Quizzes, Polls & much more. Explore now!.

Catch your daily dose of Fashion, Taylor Swift, Health, Festivals, Travel, Relationship, Recipe and all the other Latest Lifestyle News on Hindustan Times Website and APPs.
SHARE THIS ARTICLE ON